Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Hepatology (Baltimore, Md.)|November 10, 2018
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids SynthesisEva Santamaría, Carlos M Rodríguez-Ortigosa, Iker Uriarte, et al.
Journal of Hepatology|June 24, 2022
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammationIbone Labiano, Aloña Agirre-Lizaso, Paula Olaizola, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 20, 2024
New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental studyIker Uriarte, Eva Santamaria, Amaya López-Pascual, et al.
Clinical Science (London, England : 1979)|September 20, 2024
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)Amaya Lopez-Pascual, Joan S Russo-Cabrera, Nuria Ardaiz, et al.
Nature Communications|September 4, 2025
Identification of Neuritin 1 as a local metabolic regulator of brown adipose tissueManuela Sánchez-Feutrie, Montserrat Romero, Sónia R Veiga, et al.
Journal of Hepatology|June 6, 2015
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver diseasePatricia Munoz-Garrido, José J G Marin, María J Perugorria, et al.
JAMA Internal Medicine|January 31, 2017
Implementation of Lung Cancer Screening in the Veterans Health AdministrationLinda S Kinsinger, Charles Anderson, Jane Kim, et al.
Hepatology (Baltimore, Md.)|April 8, 2022
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemiaMarta Alonso-Peña, Ricardo Espinosa-Escudero, Elisa Herraez, et al.
JHEP Reports : Innovation in Hepatology|May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injuryPaula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Pageof 14